While cancer cells are often hyper-dependent on HR mediators such as RPA and RAD51 or replication checkpoints (e.g. ATR/CHK1) owing to oncogene-driven stress and checkpoint erosion, normal proliferating tissues still require baseline DDR, making myelosuppression and gastrointestinal toxicity recurring on-target effects. Here, CHEK1 is linked to cancer.